3 completed, 1 terminated. 4 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Completed 3, Terminated 1 |
Follow cilofexor: new trials by email Literature Review of cilofexor trials Research Report on cilofexor
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of Semaglutide, and Cilofexor/Firsocostat, Alone and in Combination, in Adults With Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH) Semaglutide (SEMA), Cilofexor (CILO)/Firsocostat (FIR), PTM SEMA - Nonalcoholic Steatohepatitis | Phase 2 | Completed | Gilead Sciences | 457 | 2021-08-09 | 2025-11-26 |
| Safety, Tolerability, and Efficacy of Monotherapy and Combination Regimens in Participants With Nonalcoholic Steatohepatitis (NASH) Semaglutide, Firsocostat, Cilofexor - Nonalcoholic Steatohepatitis | Phase 2 | Completed | Gilead Sciences | 109 | 2019-07-29 | 2021-07-15 |
| Study to Evaluate the Safety, Tolerability, and Efficacy of Cilofexor in Adults With Primary Biliary Cholangitis Without Cirrhosis Cilofexor, Placebo to match cilofexor - Primary Biliary Cholangitis | Phase 2 | Terminated | Gilead Sciences | 71 | 2016-12-01 | 2020-09-22 |
| Study to Evaluate the Safety, Tolerability, and Efficacy of Cilofexor in Adults With Primary Sclerosing Cholangitis Without Cirrhosis Cilofexor, Placebo to match cilofexor - Primary Sclerosing Cholangitis | Phase 2 | Completed | Gilead Sciences | 52 | 2016-11-29 | 2021-06-07 |
Non-alcoholic Fatty Liver Disease (2) · Cholangitis, Sclerosing (1) · Liver Cirrhosis, Biliary (1)
Gilead Sciences (4)
United States (4) · Canada (3) · Austria (2) · United Kingdom (2) · Australia (1) · France (1) · Japan (1) · Puerto Rico (1) · Spain (1)
2016 (2)